Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr:162:108132.
doi: 10.1016/j.diabres.2020.108132. Epub 2020 Mar 29.

COVID-19, diabetes mellitus and ACE2: The conundrum

Rimesh Pal  1 , Anil Bhansali  2
Affiliations
Comment

COVID-19, diabetes mellitus and ACE2: The conundrum

Rimesh Pal et al. Diabetes Res Clin Pract. 2020 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic diagram depicting interplay between SARS-CoV-2 and pneumocyte. SARS-CoV-2 gains entry into the pneumocyte using angiotensin-converting enzyme 2 (ACE2) as a receptor. ACE2 is upregulated with the prior use of angiotensin-converting enzyme inhibitors (ACEi)/angiotensin-receptor blockers (ARBs). Following entry into the pneumocyte, the virus replicates and ACE2 gets downregulated. As a result, there is reduced degradation of angiotensin-II which in turn leads to increased secretion of aldosterone and subsequent renal potassium wasting.
See this image and copyright information in PMC

Comment on

  • Clinical Characteristics of Coronavirus Disease 2019 in China.
    Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Guan WJ, et al. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28. N Engl J Med. 2020. PMID: 32109013 Free PMC article.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]; 2020 [cited 2020 Mar 20]; Available from: http://www.nejm.org/doi/10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA [Internet]; 2020 [cited 2020 Mar 21]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2762130. - PubMed
    1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med [Internet]; 2020 [cited 2020 Mar 20]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213260020300795. - PMC - PubMed
    1. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med [Internet]; 2020 [cited 2020 Mar 21]; Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184. - PMC - PubMed
    1. Hong K.-W., Cheong H.J., Choi W.S., Lee J., Wie S.-H., Baek J.H. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother. 2014;20:9–14. - PubMed

Substances